Expansion
- Agonist antibodies against the flk2/flt3 receptor and uses thereof
- Amino acid derivatives
- Amino terminal substance P compositions and methods for using the same
- Bcr-Abl directed compositions and uses for inhibiting Philadelphia chromosome stimulated cell growth
- Bivalent molecules that form an activating complex with an erythropoietin receptor
- Bone morphogenic protein-16 (BMP-16) compositions
- Cell culturing and storage systems, devices and methods
- Combined regulation of neural cell production
- Composition and method for culturing potentially regenerative cells and functional tissue-organs in vitro
- Composition of c-kit ligand, GM-CSF, and TNF-?a and method of use
- Compositions and therapeutic methods using morphogenic proteins and stimulatory factors
- Conditioned cell culture medium compositions and methods of use
- Crystal of fibroblast growth factor receptor 1 in complex with fibroblast growth factor
- Culture of totipotent embryonic inner cells mass cells and production of bovine animals
- Differentiation inhibitor
- DNA encoding stem cell factor
- DNA sequences encoding fusions of DNA repair proteins and uses thereof
- DNA sequences encoding fusions of DNA repair proteins and uses thereof
- DNS encoding stem cell factor
- Efficient culture of stem cells for the production of hemoglobin
- Formative agent of protein complex
- Growth of human Mesenchymal Stem Cells (hMSC) using umbilical cord blood serum and the method for the preparation thereof
- Hematopoietic stem cell proliferating agents
- Hemoglobin alpha and beta chain peptide fragments useful for inhibiting stem cell proliferation
- Hemopoietic stem cell multiplier
- Hepes based basal nutrient medium for the isolation and culturing of stem cells
- High dose radionuclide complexes for bone marrow suppression
- HTm4 methods of treatment and assays, agonists and antagonists
- Human growth hormone to stimulate hematopoiesis and immune reconstitution after hematopoietic stem cell transplantation in humans
- Human jagged polypeptide, encoding nucleic acids and methods of use
- Hypoxia mediated neurogenesis
- II adaptin
- In vitro mass production of human erythroid cells from the blood of normal donors and thalassemic patients
- In vivo genetic modification of growth factor-responsive neural precursor cells
- Infusible grade short-term cell storage medium
- Infusion systems for creating microenvironments in a living body
- Inhibitor of stem cell proliferation and uses thereof
- Inhibitor of stem cell proliferation and uses thereof
- Ligands for flt3 receptors
- Low oxygen culturing of central nervous system progenitor cells
- Manipulation of non-terminally differentiated cells using the notch pathway
- Method for enhancing the effciency of gene transfer with stem cell factor (SCF) polypeptide
- Method for gene transfer into cells activated from a quiescent state
- Method for increasing hematopoietic progenitor cells by stem cell factor polypeptides
- Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cells
- Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation
- Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation
- Method for promoting mesenchymal stem and lineage-specific cell proliferation
- Method for propagation of insecta germ cells
- Method of decreasing radiation or radio-mimetic chemotherapy for hematopoietic pluripotent cell engraftment
- Method of decreasing radiation or radio-mimetic chemotherapy for hematopoietic pluripotent cell engraftment
- Method of determining cytokine dosage for myelosuppressive state
- Method of enhancing proliferation or differentiation of hematopoietic stem cells using Wnt polypeptides
- Method of inducing neuronal production in the brain and spinal cord
- Methods and compositions for modulation and inhibition of telomerase in vitro
- Methods and compositions for the ex vivo replication of stem cells, for the optimization of hematopoietic progenitor cell cultures, and for increasing the metabolism, GM-CSF secretion and/or IL-6 secretion of human stromal cells
- Methods and device for culturing human hematopoietic cells and their precursors
- Methods and devices for inhibiting hair growth and related skin treatments
- Methods and devices for the long-term culture of hematopoietic progenitor cells
- Methods for increasing hematopoietic cells
- Methods for the treatment of bone resorption disorders, including osteoporosis
- Methods for use of Mpl ligands with primitive human hematopoietic stem cells
- Methods for use of Mpl ligands with primitive human stem cells
- Methods for using the obese gene and its gene product to stimulate hematopoietic development
- Methods of culturing embryonic stem cells and controlled differentiation
- Methods of making conditioned cell culture medium compositions
- Methods of proliferating undifferentiated neural cells
- Methods of use of FGF homologs
- Methods, compositions and devices for growing human hematopoietic cells
- Methods, compositions and kits for promoting recovery from damage to the central nervous system
- Nitrobenzylmercaptopurineriboside (NBMPR)-insensitive, equilibrative, nucleoside transport protein, nucleic acids encoding the same and methods of use
- Polypetides that include conformation-constraining groups which flank a protein-protein interaction site
- Procedure for specific replacement of a copy of a gene present in the recipient genome by the integration of a gene different from that where the integration is made
- Procedure for specific replacement of a copy of a gene present in the recipient genome by the integration of a gene different from that where the integration is made
- Proliferation of hepatocyte precursors
- Protein tyrosine phosphatases
- Radioimmunotherapy of lymphoma using anti-CD20 antibodies
- Radioimmunotherapy of lymphoma using anti-CD20 antibodies
- Radioimmunotherapy of lymphoma using anti-CD20 antibodies
- Recombinant human erythropoietin mutants
- Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions
- Serum-free medium for mesenchymal stem cells
- Stem cell factor
- Stem cell factor and compositions
- Stem cell factor formulations and methods
- Stem cell factor formulations and methods
- Stem cell inhibiting proteins
- Stimulator of stem cell division
- Stroma-derived stem cell proteoglycan growth factor
- Therapeutic compositions containing glutathione analogs
- Therapeutic uses for nitric oxide inhibitors
- Tripeptide and tetrapeptide thioethers
- Use of c-kit ligand with TNF-?a and hematopoietic factors for the expansion or differentiation of hematopoietic cells
- Use of GHRH-RP to stimulate stem cell factor production
- Use of Xenopus laevis oocytes a microincubators
- Uses of Wnt polypeptides
- Vitro maintenance of hematopoietic stem cells